Advance Create Co., Ltd.TSE: 8798

Summary of Consolidated Financial Results for the Six Months Ended March 31, 2021(Based on Japanese GAAP)

· Issued by Advance Create Co., Ltd.

3. Forecast of consolidated financial results for the year ending September 30, 2021 (from October 1, 2020 to September 30, 2021)

Percentages indicate year-on-year changes

Net sales

Operating profit

Ordinary profit

Profit attributable to

Earnings per share

owners of parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

12,000

14.2

1,800

52.0

1,700

55.1

1,100

57.1

50.98

(Note) Revision of earnings forecast to the latest announcement No

The company conducted a stock split on April 1, 2021, at a ratio of 2 ordinary shares for each ordinary share. Consequently, net income per share on consolidated earnings forecast are calculated on the assumption that the said stock split was implemented at the beginning of the previous consolidated fiscal year.

4. Notes

(1)

Changes in significant subsidiaries during the six months ended March 31, 2021

No

(changes in specified subsidiaries resulting in the change in scope of consolidation):

(2)

Application of special accounting methods for preparing quarterly consolidated financial statements:

No

(3)

Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements

Changes in accounting policies due to revisions to accounting standards and other regulations:

No

Changes in accounting policies due to other reasons:

No

Changes in accounting estimates:

No

Restatement of prior period financial statements:

No

(4)

Number of issued shares (common shares)

Total number of issued shares at the end of the period (including treasury shares)

As of March 31, 2021

22,201,400 shares

As of September 30, 2020

22,075,200 shares

Number of treasury shares at the end of the period

As of March 31, 2021

580,478 shares

As of September 30, 2020

600,478 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)

Six months ended March 31, 2021

21,526,310 shares

Six months ended March 31, 2020

20,740,266 shares

2

Quarterly consolidated financial statements

Consolidated balance sheets

(Thousands of yen)

As of September 30, 2020

As of March 31, 2021

Assets

Current assets

Cash and deposits

2,632,288

2,274,826

Notes and accounts receivable - trade

1,099,522

1,755,889

Accounts receivable - other

2,120,899

2,752,408

Income taxes receivable

15,225

-

Other

695,462

793,734

Total current assets

6,563,398

7,576,858

Non-current assets

Property, plant and equipment

617,172

559,062

Intangible assets

Software

518,631

643,031

Other

167,744

86,849

Total intangible assets

686,376

729,880

Investments and other assets

Investment securities

351,506

319,190

Guarantee deposits

678,655

536,472

Insurance funds

716,258

716,258

Deferred tax assets

271,683

291,853

Other

403,056

400,164

Total investments and other assets

2,421,161

2,263,939

Total non-current assets

3,724,710

3,552,882

Deferred assets

24,688

21,319

Total assets

10,312,797

11,151,060

Liabilities

Current liabilities

Current portion of bonds payable

200,000

200,000

Income taxes payable

106,616

417,716

Accounts payable - other

1,087,762

1,094,169

Deposits received

410,212

593,152

Lease obligations

80,116

75,803

Provision for bonuses

183,305

178,449

Asset retirement obligations

6,777

-

Other

623,855

527,918

Total current liabilities

2,698,647

3,087,209

Non-current liabilities

Long-term borrowings

127,630

108,910

Bonds payable

800,000

700,000

Lease obligations

369,609

331,611

Retirement benefit liability

356,206

373,377

Asset retirement obligations

214,016

205,168

Other

136,594

144,251

Total non-current liabilities

2,004,057

1,863,318

Total liabilities

4,702,704

4,950,527

3

(Thousands of yen)

As of September 30, 2020

As of March 31, 2021

Net assets

Shareholders' equity

Share capital

2,954,496

3,011,677

Capital surplus

381,117

438,298

Retained earnings

2,586,305

3,068,470

Treasury shares

(443,976)

(425,811)

Total shareholders' equity

5,477,943

6,092,635

Accumulated other comprehensive income

Valuation difference on available-for-sale

128,534

105,228

securities

Total accumulated other comprehensive income

128,534

105,228

Share acquisition rights

3,615

2,668

Total net assets

5,610,092

6,200,532

Total liabilities and net assets

10,312,797

11,151,060

4

Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative)

Consolidated statements of income (cumulative)

(Thousands of yen)

Six months ended

Six months ended

March 31, 2020

March 31, 2021

Net sales

5,575,599

5,778,166

Cost of sales

1,602,215

1,313,441

Gross profit

3,973,384

4,464,725

Selling, general and administrative expenses

3,116,466

3,243,276

Operating profit

856,918

1,221,448

Non-operating income

Interest and dividend income

2,415

2,421

Gain on forfeiture of unclaimed dividends

498

414

Guarantee commission received

4,090

4,090

Other

3,859

1,922

Total non-operating income

10,863

8,847

Non-operating expenses

Interest expenses

5,676

5,387

Guarantee commission

300

708

Commission expenses

39,911

56,187

Other

250

3,541

Total non-operating expenses

46,138

65,825

Ordinary profit

821,643

1,164,470

Extraordinary income

Gain on reversal of share acquisition rights

400

-

Total extraordinary income

400

-

Extraordinary losses

Loss on store closings

-

15,793

Loss on retirement of non-current assets

-

3,224

Total extraordinary losses

-

19,018

Profit before income taxes

822,043

1,145,451

Income taxes - current

273,586

390,106

Income taxes - deferred

(4,463)

(4,102)

Total income taxes

269,122

386,003

Profit

552,920

759,448

Profit attributable to owners of parent

552,920

759,448

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Company analysis